Advanced search
Publication Cover
Expert Review of Vaccines Volume 21, 2022 - Issue 9
Submit an article Journal homepage
4,133
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Reactogenicity and immunogenicity of BNT162b2 or mRNA-1273 COVID-19 booster vaccinations after two doses of BNT162b2 among healthcare workers in Japan: a prospective observational study

Toshio Naitoa Department of General Medicine, Juntendo University Faculty of Medicine, Tokyo, JapanORCID Iconhttps://orcid.org/0000-0003-1646-9930View further author information
ORCID Icon,
Nao Tsuchidab Department of Clinical Trials, Clinical Research Center, National Hospital Organization Headquarters, Tokyo, JapanView further author information
,
Susumu Kusunokic Japan Community Health Care Organization Headquarters, Tokyo, JapanView further author information
,
Yoshihiro Kanekod Japan Organization of Occupational Health and Safety, Kanagawa, JapanView further author information
,
Morikuni Tobitae Medical Technology Innovation Center, Juntendo University, Tokyo, JapanView further author information
,
Satoshi Horif Department of Infection Control Science, Juntendo University, Graduate School of Medicine, Tokyo, JapanView further author information
&
Suminobu Itoa Department of General Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan;e Medical Technology Innovation Center, Juntendo University, Tokyo, JapanCorrespondence[email protected]
View further author information
 show all
Pages 1319-1329 | Received 13 May 2022, Accepted 21 Jun 2022, Published online: 04 Jul 2022

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Akio Onishi, Yayoi Matsumura-Kimoto, Shinsuke Mizutani, Taku Tsukamoto, Takahiro Fujino, Akihiro Miyashita, Daichi Nishiyama, Kazuho Shimura, Hiroto Kaneko, Eri Kawata, Ryoichi Takahashi, Tsutomu Kobayashi, Hitoji Uchiyama, Nobuhiko Uoshima, Yoko Nukui, Yuji Shimura, Tohru Inaba & Junya Kuroda. (2023) Impact of Treatment with Anti-CD20 Monoclonal Antibody on the Production of Neutralizing Antibody Against Anti–SARS-CoV-2 Vaccination in Mature B-Cell Neoplasms. Infection and Drug Resistance 16, pages 509-519.
Read now

Articles from other publishers (5)

Nancy Flores-Lastra, Josue Rivadeneira-Dueñas, Luis Fuenmayor-González, Glenda Guayasamín-Tipanta, Michelle Jácome-García, Tamara Otzen & Carlos Manterola. (2023) Safety Profile of Homologous and Heterologous Booster COVID-19 Vaccines in Physicians in Quito-Ecuador: A Cross-Sectional Study. Vaccines 11:3, pages 676.
Crossref
Lucrezia Puccini, Michela Fantini, Carlo Biagetti, Raffaella Angelini, Giorgio Dirani, Laura Grumiro, Pasqua Schiavone, Monica Sparacino, Simona Semprini, Vittorio Sambri & Monica Cricca. (2023) Kinetics of dried blood spot-measured anti-SARS-CoV2 Spike IgG in mRNA-vaccinated healthcare workers. Frontiers in Microbiology 14.
Crossref
Daisuke Hisamatsu, Akari Ikeda, Lisa Ito, Yasushi Matsushita, Makoto Hiki, Hirotake Mori, Yoko Tabe, Toshio Naito & Chihiro Akazawa. (2022) Longitudinal Analyses after COVID-19 Recovery or Prolonged Infection Reveal Unique Immunological Signatures after Repeated Vaccinations. Vaccines 10:11, pages 1815.
Crossref
Suminobu ITO. (2022) 2 ．Large Scale Cohort Study in Practice2 ．大規模コホート調査の実際. Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku 27:2, pages 71-77.
Crossref
Jie Deng, Yirui Ma, Qiao Liu, Min Du, Min Liu & Jue Liu. (2022) Comparison of the Effectiveness and Safety of Heterologous Booster Doses with Homologous Booster Doses for SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health 19:17, pages 10752.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.